Employees: 1,086
Size Tactile Systems Technology (TCMD) is a United States Health Care company (Medical Specialties) with a market value of $592M, the 2558th largest of 3,085 United States companies the cockpit tracks. Shares closed at $26.42 on 18 Nov 2026.
Performance Over six months the shares gained 6.4%, against -20.3% for the median peer and -2.2% for the United States market (cap-weighted) — 7th highest of 19 in its peer set.
Growth Revenue grew 14.4% over the last twelve months (peer median +6.5%); the operating margin is 9.5% (peer median 7.4%).
Valuation It trades at 21.1× forward earnings against a peer median of 23.5× (6th cheapest of 12).
Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +12%, so the hurdle is -4 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 6.0 points above its cost of capital (9.7% WACC).
Short interest Short interest is 12.4% of the free float (30 Oct 2026).
Next results Next results expected around 23 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $356M | $330M | $293M | $274M | $247M |
| Revenue growth | — | +12% | +7% | +11% | — |
| Gross profit | $272M | $248M | $214M | $193M | $172M |
| EBITDA | $40.6M | $35.9M | $29.0M | $22.1M | $4.17M |
| Net income | $23.8M | $19.1M | $17.0M | $28.5M | -$17.9M |
| Free cash flow | $29.0M | $40.4M | $38.3M | $33.4M | $3.39M |
| Capital expenditure | $3.33M | $2.54M | $2.51M | $2.48M | $1.92M |
| Total debt | $17.1M | $16.0M | $45.1M | $50.4M | $72.2M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | TCMD | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +12.3% | -3.5% | 4th highest of 19 |
| 6-month return | +6.4% | -20.3% | 7th highest of 19 |
| Distance from 52-week high | -30.1% | -35.0% | 8th highest of 20 |
| Revenue growth (TTM) | +14.4% | +6.5% | 10th highest of 20 |
| Operating margin | 9.5% | 7.4% | 8th highest of 20 |
| Forward P/E | 21.1× | 23.5× | 6th cheapest of 12 |
| Growth the price implies (Req g, 7 yrs) | 8.4% | 0.4% | 5th most demanding of 10 |
| Growth delivered (Del g) | +12.0% | +6.7% | 5th highest of 10 |
| Hurdle (Req g minus delivered) | -3.6 pp | -10.7 pp | 5th most demanding of 10 |
| ROIC minus cost of capital | +6.0 pp | -3.3 pp | 6th highest of 19 |
| EV / EBITDA | 13.2× | 18.6× | 3rd cheapest of 7 |
| Net debt / EBITDA | -1.4× | -1.0× | 4th least indebted of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Tactile Systems Technology TCMD | United States | $592M | +6% | +14% | 9% | 21.1× | 8.4% | +12.0% |
| Hangzhou AGS MedTech 688581.SS | China | $590M | -22% | -18% | 33% | 18.9× | 0.4% | +27.8% |
| vVARDIS VVVV | United States | $594M | n/a | +148% | -72% | n/a | n/a | n/a |
| Ningbo David Medical Device 300314.SZ | China | $589M | +25% | +19% | 11% | 12.0× | n/a | n/a |
| Sahajanand Medical Technologies SMT.NS | India | $595M | n/a | n/a | n/a | n/a | n/a | n/a |
| Orchestra BioMed OBIO | United States | $587M | +87% | +1,007% | -195% | n/a | n/a | n/a |
| Sight Sciences SGHT | United States | $599M | +122% | +16% | -30% | n/a | n/a | n/a |
| Medistim MEDI.OL | Norway | $599M | +32% | +19% | 29% | 31.8× | -1.2% | +14.5% |
| Nanosonics NAN.AX | Australia | $599M | -4% | +3% | 7% | 98.6× | 35.3% | +6.7% |
| Jiangsu Hanvo Safety Product 300952.SZ | China | $575M | -38% | +6% | 8% | 39.7× | n/a | n/a |
| Xvivo Perfusion XVIVO.ST | Sweden | $611M | -32% | +18% | 12% | 53.1× | 35.9% | +35.2% |
| Pacific Biosciences of California PACB | United States | $573M | +54% | +4% | -98% | n/a | n/a | n/a |
| Beijing Chunlizhengda Medical Instruments 688236.SS | China | $618M | -27% | -13% | 31% | 17.4× | -8.5% | +2.2% |
| Wuhan Huakang Century Clean Technology 301235.SZ | China | $563M | -57% | +28% | 7% | 33.7× | n/a | n/a |
| Cowealth Medical China 603122.SS | China | $562M | -34% | -18% | -5% | n/a | n/a | n/a |
| SunMax Biotechnology 4728.TWO | Taiwan | $630M | 0% | +19% | 51% | n/a | -2.6% | +18.8% |
| Contec Medical Systems 300869.SZ | China | $547M | -26% | -2% | -16% | n/a | 15.0% | -19.8% |
| AK Medical 1789.HK | Hong Kong | $642M | -23% | +16% | 26% | 10.5× | -11.5% | +6.7% |
| Zhejiang Gongdong Medical Technology 605369.SS | China | $542M | -21% | +6% | 9% | 23.5× | 10.2% | +6.5% |
| QuidelOrtho QDEL | United States | $657M | -20% | -5% | -2% | 10.7× | n/a | n/a |
| Jin Medical International ZJYL | United States | $532M | +47% | -14% | 2% | n/a | n/a | n/a |